Inflation Impact Must Be Considered During Generics Pricing, Says Canadian Study
Price Regulation Limits Sector’s Ability To Absorb Cost Increases
Canadian provinces must consider the impact of inflation on generic drugs during the next round of off-patent price setting, says a study from Aviseo and the Canadian Generic Pharmaceutical Association.
